查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931157

京岡黴素市場按作物類型、製劑類型、應用方法和最終用途分類，全球預測（2026-2032年）

Jinggangmycin Market by Crop Type, Formulation Type, Application Method, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，京岡黴素市值將達到 1.3015 億美元，到 2026 年將成長至 1.3669 億美元，到 2032 年將達到 1.9003 億美元，複合年成長率為 5.55%。

關鍵市場統計數據
基準年 2025 1.3015億美元
預計年份：2026年 1.3669億美元
預測年份 2032 1.9003億美元
複合年成長率 (%) 5.55%

全面介紹京光黴素的農業效用、監管挑戰以及推動其在作物保護中廣泛應用的科學進展。

京光黴素因其生物來源、靶向定向以及研發機構和商業相關人員的日益關注，在現代作物保護領域佔據著獨特的地位。京光黴素最初是為防治水稻種植區的真菌病害而開發和應用的，但其在多種作物和農業系統中的廣泛適用性引起了人們的關注。日益嚴格的監管審查和不斷發展的管理實踐，使得人們越來越需要明確京光黴素的安全使用、殘留管理和環境影響等方面的問題。

不斷變化的監管、製劑創新和合作研究如何重塑全球京光黴素的應用和管理實踐

過去幾年，由於監管重新評估、製劑創新以及對綜合蟲害管理的日益重視，京岡黴素市場格局發生了翻天覆地的變化。主要產區的監管機構加強了殘留監測和控制框架，鼓勵生產商和經銷商投資於合規體系和可靠的分析方法。同時，製劑科學的進步帶來了新的給藥機制，提高了穩定性，減少了非標靶暴露，並延長了施用期。

評估關稅引發的供應鏈壓力因素、採購應對措施以及影響2025年京光黴素生產連續性和供應的韌性策略

近期主要經濟體的貿易政策發展和關稅措施，為支持活性成分、原料藥和農業投入品（例如京光黴素）國際分銷的供應鏈帶來了新的複雜性。關稅及相關貿易措施會增加採購成本，改變採購偏好，並為依賴跨境原料和包裝組件供應的製造商帶來時間上的不確定性。因此，進口商和製劑製造商必須重新評估籌資策略和庫存緩衝，以確保對生產商和調查計畫的持續供應。

細分主導對產品開發、監管文件編制以及作物類型、製劑形式、應用方法和最終用戶群等方面的應用策略產生影響

細分市場分析揭示了施用方法、製劑形式、作物類型和最終用戶分類如何影響京岡黴素的產品開發重點和推廣機制。在考察不同作物類型時，特別是水果蔬菜和水稻，其推廣趨勢有差異。在水稻種植系統中，京岡黴素歷來被優先用於防治紋枯病，並已建立了較為標準化的施用通訊協定。相較之下，水果蔬菜則需要客製化的殘留管理、品種相容性測試以及更嚴格的施用時間，才能達到品質標準。

美洲、歐洲、中東和非洲以及亞太地區的監管差異和農業現狀，影響技術的採納路徑和管理重點。

區域趨勢將對京光黴素的監管要求、應用模式和商業化路徑產生深遠影響。在美洲，法規結構強調殘留限量、環境風險評估和供應鏈可追溯性，鼓勵製劑生產商採用保守的標籤標註和可靠的分析檢驗。該地區的生產者網路傾向於強調綜合蟲害管理（IPM）方法以及在不同氣候條件下經證實的療效，促使企業與當地農業推廣服務機構合作開發管理材料。

競爭定位、夥伴關係模式和能力差異化因素決定了參與京岡黴素研發、配製和分銷的相關人員。

京岡黴素相關產品的研發競爭格局複雜多樣，既有專業生物農藥製劑生產商，也有探索佐劑組合的合成化學公司，還有致力於應用科學研究的科研機構。主要參與者正著力透過提高製劑穩定性、減少殘留和加強生產品管來實現差異化，同時也投資準備各監管機構要求的資料包。私人企業與學術機構之間的夥伴關係對於建立產品功效和安全性證據基礎至關重要，而這些證據對於產品的廣泛應用至關重要。

為加強供應鏈、提升製劑性能、建立制度化管理機制，加速井岡黴素的負責任引進，經營團隊可採取切實可行的策略措施。

產業領導者應採取協作策略，在短期業務永續營運與產品管理和配方科學方面的長期創新之間取得平衡。首先，優先考慮供應商多角化和加強品質保證可以降低跨境貿易中斷和原物料價格波動帶來的風險。投資於替代採購管道並對二級供應商進行資格認證，將確保生產連續性，同時保持合規性。

基於嚴謹的多源調查方法，結合專家訪談、實地測試、監管審查和基於情境的供應鏈分析，得出可操作的洞見。

本分析的調查方法結合了多學科證據，以確保獲得可靠的實務知識。關鍵資訊來自對農藝師、製劑科學家、監管專家和商業種植者的結構化訪談，涵蓋了不同的操作觀點。田間試驗觀察和對照試驗報告為探討施用方法的有效性和殘留問題提供了實證依據，而技術文件和同行評審文獻則有助於評估活性成分的行為和製劑間的相互作用。

需要整合並協調技術、監管和營運要求，以實現京光黴素在作物系統中的負責任、有效和永續應用。

總之，儘管京光黴素在某些作物系統中仍是一種有效的病害防治工具，但其未來的推廣應用將取決於製劑技術的協同進步、監管的統一性以及供應鏈的韌性。相關人員必須應對多重壓力，包括日益嚴格的監管、不斷發展的應用技術以及影響原料供應和成本結構的貿易趨勢。農業研究和製劑科學正在拓展該產品的效用，但負責任的管理和在地化的經驗數據對於其長期持續應用仍然至關重要。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依作物類型分類的京岡黴素市場

  • 水果和蔬菜
  • 米

9. 京岡黴素市場按劑型類型分類

  • 乳化濃縮液
  • 水分散性顆粒
  • 可濕性粉

第10章 京岡黴素市場依應用領域分類

  • 葉面噴布
  • 種子處理
  • 土壤灌溉

第11章 京岡黴素市場依最終用途分類

  • 商業農場
    • 大型農場
    • 小規模農場
  • 研究所

第12章 京岡黴素市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 京岡黴素市場（依集團分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國京岡黴素市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國井岡黴素市場

第16章：中國井岡黴素市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Anhui Hualong Technology Co., Ltd.
  • BASF SE
  • Guangdong Huijin Chuan Biological Technology Co., Ltd.
  • Hubei Daonuo Bioengineering Co., Ltd.
  • Hubei Zhengyang Biological Technology Co., Ltd.
  • Jiangsu Woyuan Bioengineering Co., Ltd.
  • Qingdao Kangyuan Bioengineering Co., Ltd.
  • Shandong Lvfeng Bioengineering Co., Ltd.
  • Syngenta AG
  • Zhejiang Yunnan Biotech Co., Ltd.
Product Code: MRR-7B550E008D89

The Jinggangmycin Market was valued at USD 130.15 million in 2025 and is projected to grow to USD 136.69 million in 2026, with a CAGR of 5.55%, reaching USD 190.03 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 130.15 million
Estimated Year [2026] USD 136.69 million
Forecast Year [2032] USD 190.03 million
CAGR (%) 5.55%

Comprehensive context on jinggangmycin's agronomic utility, regulatory pressure points, and the scientific advances shaping adoption across crop protection landscapes

Jinggangmycin occupies a unique position in contemporary crop protection due to its biological origin, targeted efficacy, and growing interest among research and commercial stakeholders. Initially developed and adopted within rice-producing regions to combat fungal diseases, the compound has attracted attention for its broader applicability across diverse crops and farming systems. Regulatory scrutiny and evolving stewardship practices have elevated the need for clarity around safe use, residue management, and environmental considerations.

This report synthesizes technical performance data, formulation developments, supply chain dynamics, and stakeholder behavior to provide a cohesive introduction to jinggangmycin's role in modern agriculture. The introduction establishes the scientific basis of the molecule and contextualizes recent advances in production methods, which have improved consistency and enabled new formulation formats. It also highlights the interplay between agronomic need and product development, showing how growers and researchers are jointly driving innovation.

As adoption patterns shift, decision-makers must reconcile crop protection efficacy with regulatory compliance and market access. Consequently, this section frames the core issues that follow: regulatory momentum, formulation innovation, application practices, and the economic levers that influence adoption across farm types and research institutions. By setting this foundation, stakeholders can better interpret subsequent analyses and translate insights into practical strategies.

How evolving regulatory scrutiny, formulation breakthroughs, and collaborative research are reshaping jinggangmycin deployment and stewardship practices globally

Over the past several years, the landscape around jinggangmycin has undergone transformative shifts driven by regulatory reevaluation, formulation innovation, and an increased emphasis on integrated pest management. Regulatory agencies in key producing regions have intensified residue monitoring and stewardship frameworks, prompting manufacturers and distributors to invest in compliance systems and robust analytical methods. Concurrently, advances in formulation science have delivered new delivery mechanisms that improved stability, reduced non-target exposure, and expanded application windows.

These changes have accelerated collaboration between academia and industry, with field trials designed to quantify efficacy under diverse climatic and agronomic conditions. As a result, growers have begun to refine application timing and integrate the product more deliberately into resistance management plans. At the same time, supply chain actors have responded by optimizing production processes to support varied formulation demands, which in turn has influenced distribution strategies and inventory management.

Taken together, these shifts are moving the sector toward more evidence-driven deployment of jinggangmycin, where data from targeted trials and regulatory compliance requirements shape commercial decisions. The trajectory suggests continued maturation of best practices as stakeholders align on safe, effective, and sustainable use models that reduce environmental impact while maintaining crop protection outcomes.

Assessment of tariff-driven supply chain stressors, sourcing responses, and resilience strategies that influence production continuity and access to jinggangmycin in 2025

Recent trade policy developments and tariff measures implemented by major economies have introduced new complexities into the supply chains that underpin active ingredient availability, formulation inputs, and international distribution of agricultural inputs such as jinggangmycin. Tariffs and related trade measures raise procurement costs, shift sourcing preferences, and can create timing uncertainties for manufacturers reliant on cross-border supply of raw materials and packaging components. Importers and formulators must therefore reassess sourcing strategies and inventory buffers to maintain continuity of supply to growers and research programs.

At the operational level, increased trade frictions have incentivized local sourcing and nearshoring of key feedstocks when feasible, prompting investment in domestic manufacturing capabilities and alternative supplier relationships. These adaptive measures can improve resilience but often require capital expenditure, longer qualification cycles for new suppliers, and updated quality assurance protocols. For research institutions and commercial farms, the immediate effect has been a heightened focus on procurement planning and scenario analysis to account for potential cost volatility and lead-time fluctuations.

Looking ahead, stakeholders will need to balance short-term operational adjustments with strategic investments in supply chain diversification and quality governance. By anticipating tariff-driven pressures and instituting robust supplier qualification processes, organizations can mitigate disruption and maintain access to critical crop protection tools while protecting product integrity and regulatory compliance.

Segment-driven implications for product development, regulatory dossiers, and adoption strategies spanning crop types, formulation formats, application methods, and end-user profiles

Segmentation-driven insights reveal how application, formulation, crop type, and end-user categorization influence product development priorities and adoption mechanisms for jinggangmycin. When considered by crop type - specifically fruits and vegetables versus rice - adoption dynamics diverge: rice systems historically prioritized jinggangmycin for sheath blight control and have more standardized application protocols, whereas fruits and vegetables require tailored residue management, varietal compatibility testing, and narrower application timings to meet quality standards.

Formulation type is another critical determinant; emulsifiable concentrates, water dispersible granules, and wettable powders each present distinct handling, stability, and efficacy profiles that affect grower preference and regulatory submission requirements. Emulsifiable concentrates can offer rapid uptake but may raise formulation management concerns, while water dispersible granules and wettable powders can simplify transport and reduce spill risk but necessitate validation of dispersion characteristics.

Application method also shapes operational adoption: foliar spray, seed treatment, and soil drench each demand different dosing paradigms, equipment configurations, and timing relative to crop phenology. These methods drive how extension services and agronomists craft use recommendations. End use categorization further refines insight; commercial farms and research institutions exhibit different procurement cycles and evidence needs, and within commercial farms the distinction between large-scale and small-scale operations influences purchasing power, application infrastructure, and risk tolerance. Integrating these segmentation dimensions helps stakeholders prioritize formulation R&D, regulatory engagement, and tailored extension services to match real-world use cases.

Regional regulatory diversity and agronomic realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption pathways and stewardship priorities

Regional dynamics exert a profound influence on regulatory expectations, adoption patterns, and the commercial pathways for jinggangmycin. In the Americas, regulatory frameworks emphasize residue limits, environmental risk assessment, and supply chain traceability, which encourages formulators to adopt conservative labeling and robust analytical validation. Grower networks in this region often value integrated pest management approaches and documented efficacy under variable climatic conditions, prompting companies to align stewardship materials with local extension services.

Across Europe, Middle East & Africa, regulatory complexity varies considerably, from stringent approvals and public transparency in many European jurisdictions to uneven enforcement and infrastructure constraints in other parts of the region. This heterogeneity requires a flexible approach to dossier preparation, localized field data generation, and tailored risk communication strategies. In parallel, capacity-building initiatives that support safe use and monitoring can accelerate responsible adoption.

The Asia-Pacific region remains a core adopter base where historical usage patterns and agronomic familiarity support broader acceptance, particularly in rice systems. However, emerging regulatory harmonization efforts and consumer preferences for residue minimization are driving reformulation and refined application practices. Manufacturers and research organizations operating across these geographies must therefore calibrate regulatory submissions, field trial strategies, and commercial positioning to account for divergent compliance regimes, infrastructure realities, and grower priorities.

Competitive positioning, partnership models, and capability differentiators that define stakeholders engaged in jinggangmycin development, formulation, and distribution

Competitive landscapes for jinggangmycin-related development encompass a mix of specialized biopesticide formulators, synthetic chemistry firms exploring adjuvant pairings, and research institutions advancing application science. Leading actors concentrate on differentiating through formulation stability, residue mitigation, and production quality management, while also investing in data packages required by diverse regulatory authorities. Partnerships between private developers and academic groups remain central to building the efficacy and safety evidence base needed for broader adoption.

Intellectual property strategies vary by actor; some companies focus on proprietary manufacturing processes and formulation patents to secure commercial advantage, while others emphasize open scientific collaboration to accelerate validation across multiple crop systems. Distribution and channel strategies likewise differ, with some organizations prioritizing direct engagement with large commercial farm networks and others focusing on building relationships with agro-input distributors and extension services that serve smallholder operators. Across the board, transparency in quality controls, traceability of raw materials, and adherence to international best practices are increasingly viewed as competitive differentiators that can ease regulatory interactions and build trust with end users.

For stakeholders evaluating partnerships or competitive positioning, the key considerations include formulation performance, supply chain robustness, and the ability to generate regionally relevant data that supports safe, effective deployment across the intended crop and application contexts.

Practical strategic moves for executives to shore up supply chains, advance formulation performance, and institutionalize stewardship to accelerate responsible jinggangmycin adoption

Industry leaders should pursue a coordinated strategy that balances near-term operational resilience with long-term innovation in product stewardship and formulation science. First, prioritizing supplier diversification and enhanced quality assurance will reduce exposure to cross-border trade disruptions and input variability. Investing in alternative sourcing pathways and qualifying secondary suppliers can preserve production continuity while maintaining regulatory compliance.

Second, leaders should accelerate investment in formulation optimization that targets reduced non-target exposure and improved handling characteristics. By advancing emulsifiable concentrates, water dispersible granules, and wettable powders with demonstrable improvements in stability and efficacy, organizations can better align product attributes with end-user application capabilities. Third, establishing robust field trial networks that generate region-specific efficacy and residue data will streamline regulatory engagement and support targeted extension efforts. Collaborative trials with research institutions and commercial farms of different scales will create the localized evidence needed to inform safe use guidelines.

Finally, companies should adopt transparent communication strategies that educate users on integrated pest management integration, application timing, and resistance mitigation. By combining operational risk management with proactive R&D and stakeholder engagement, industry leaders can protect supply chains, accelerate responsible adoption, and unlock sustainable value from jinggangmycin deployment.

Rigorous multi-source methodology integrating expert interviews, field trials, regulatory review, and scenario-based supply chain analysis to underpin actionable findings

The research methodology underpinning this analysis combined a multi-disciplinary evidence base designed to ensure robust, actionable findings. Primary information was sourced from structured interviews with agronomists, formulation scientists, regulatory experts, and commercial growers to capture diverse operational perspectives. Field performance observations and controlled trial reports provided empirical context for application method efficacy and residue considerations, while technical dossiers and peer-reviewed literature informed assessments of active ingredient behavior and formulation interactions.

Analytical methods included cross-validation of interview insights against documented trial outcomes and regulatory guidance to identify consistent patterns and actionable implications. Supply chain analysis employed a scenario-based approach to evaluate sourcing sensitivities, manufacturing constraints, and distribution dependencies. Throughout the research process, particular attention was paid to ensuring regional representativeness, so that findings reflect distinct regulatory environments and agronomic practices across major geographies.

Quality control measures included triangulation of independent data sources, expert peer review of technical conclusions, and an audit trail for key evidence inputs. This methodological rigor supports the credibility of the insights and facilitates practical translation of findings into policy, commercial, and operational actions.

Synthesis of technical, regulatory, and operational imperatives that must align to enable responsible, effective, and sustainable jinggangmycin deployment across crop systems

In conclusion, jinggangmycin continues to present a valuable tool for targeted disease management across specific crop systems, but its future deployment will depend on coordinated advances in formulation, regulatory alignment, and supply chain resilience. Stakeholders must navigate a confluence of pressures: heightened regulatory scrutiny, evolving application practices, and trade dynamics that influence raw material availability and cost structures. While agricultural research and formulation science are extending the product's utility, responsible stewardship and regionally tailored evidence remain essential to sustaining long-term acceptance.

To capitalize on technical progress, manufacturers and distributors must focus on building robust quality systems, diversifying supply channels, and generating the localized data that regulators and growers require. At the same time, extension services and research institutions will play a pivotal role in translating trial results into practical use recommendations that protect both crop productivity and environmental health. When these elements are combined-sound science, resilient sourcing, and clear stewardship-jinggangmycin can be integrated responsibly into integrated pest management strategies that meet agronomic needs while addressing regulatory and market expectations.

The path forward requires deliberate coordination across industry, research, and regulatory stakeholders to ensure that technical innovation translates into safe, effective, and sustainable crop protection outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Jinggangmycin Market, by Crop Type

  • 8.1. Fruits & Vegetables
  • 8.2. Rice

9. Jinggangmycin Market, by Formulation Type

  • 9.1. Emulsifiable Concentrate
  • 9.2. Water Dispersible Granules
  • 9.3. Wettable Powder

10. Jinggangmycin Market, by Application Method

  • 10.1. Foliar Spray
  • 10.2. Seed Treatment
  • 10.3. Soil Drench

11. Jinggangmycin Market, by End Use

  • 11.1. Commercial Farms
    • 11.1.1. Large-Scale Farms
    • 11.1.2. Small-Scale Farms
  • 11.2. Research Institutions

12. Jinggangmycin Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Jinggangmycin Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Jinggangmycin Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Jinggangmycin Market

16. China Jinggangmycin Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Anhui Hualong Technology Co., Ltd.
  • 17.6. BASF SE
  • 17.7. Guangdong Huijin Chuan Biological Technology Co., Ltd.
  • 17.8. Hubei Daonuo Bioengineering Co., Ltd.
  • 17.9. Hubei Zhengyang Biological Technology Co., Ltd.
  • 17.10. Jiangsu Woyuan Bioengineering Co., Ltd.
  • 17.11. Qingdao Kangyuan Bioengineering Co., Ltd.
  • 17.12. Shandong Lvfeng Bioengineering Co., Ltd.
  • 17.13. Syngenta AG
  • 17.14. Zhejiang Yunnan Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL JINGGANGMYCIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL JINGGANGMYCIN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL JINGGANGMYCIN MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JINGGANGMYCIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL JINGGANGMYCIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL JINGGANGMYCIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL JINGGANGMYCIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL JINGGANGMYCIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL JINGGANGMYCIN MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL JINGGANGMYCIN MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SOIL DRENCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SOIL DRENCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SOIL DRENCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL JINGGANGMYCIN MARKET SIZE, BY LARGE-SCALE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL JINGGANGMYCIN MARKET SIZE, BY LARGE-SCALE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL JINGGANGMYCIN MARKET SIZE, BY LARGE-SCALE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SMALL-SCALE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SMALL-SCALE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL JINGGANGMYCIN MARKET SIZE, BY SMALL-SCALE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL JINGGANGMYCIN MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL JINGGANGMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS JINGGANGMYCIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL JINGGANGMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 99. GCC JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GCC JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. GCC JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. GCC JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 103. GCC JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 117. G7 JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. G7 JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. G7 JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. G7 JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 121. G7 JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 123. NATO JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NATO JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NATO JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NATO JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 127. NATO JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL JINGGANGMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA JINGGANGMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA JINGGANGMYCIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA JINGGANGMYCIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA JINGGANGMYCIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA JINGGANGMYCIN MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA JINGGANGMYCIN MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)